<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BCRX
BioCryst
$
()


  • BioCryst announces Brazilian Health Regulatory Agency approval for Orladeyo

    Today - 05:06am
  • BioCryst reports inducement grants under Nasdaq listing rule

    4/3/2024 - 07:02am
  • BioCryst reports inducement grants under Nasdaq listing rule

    3/5/2024 - 07:20am
  • BioCryst files automatic mixed securities shelf

    2/27/2024 - 17:08pm
  • BioCryst sees 2024 ORLADEYO revenue $380M-$400M

    2/26/2024 - 07:05am
  • BioCryst reports Q4 EPS (31c), consensus (24c)

    2/26/2024 - 07:03am
  • BioCryst presents real-world data on ORLADEYO

    2/23/2024 - 07:11am
  • BioCryst Pharmaceuticals announces launch of ORLADEYO in Italy

    2/19/2024 - 16:07pm
  • BioCryst reports inducement grants under Nasdaq listing rule

    2/2/2024 - 07:04am
  • Pharvaris price target raised by $2 at BofA, here's why

    1/23/2024 - 07:22am
  • Biotech Alert: Searches spiking for these stocks today

    1/10/2024 - 11:12am
  • What You Missed On Wall Street On Monday

    1/8/2024 - 16:50pm
  • What You Missed On Wall Street This Morning

    1/8/2024 - 12:09pm
  • BioCryst price target lowered by $3 at JMP Securities, here's why

    1/8/2024 - 06:18am
  • BioCryst reports preliminary Q4 ORLADEYO revenue $89.9M

    1/5/2024 - 16:02pm
dynamic_feed Breaking News